PIO 2025

We are delighted to announce that Quimigen will be partnering with the upcoming Paris Immuno-Oncology (PIO) Conference 2025, taking place on June 16–17, 2025, at the historic Cordeliers Campus in the heart of Paris.

Organized under the presidency of Prof. Guido Kroemer and hosted by the European Academy of Tumor Immunology (EATI), this high-impact scientific event brings together leading voices in oncology, immunology, and microbiology to explore new frontiers in cancer therapy.

This year’s conference is centered around two major themes:

• Tumor Immunology & Immunotherapy

• Microbiota–Immune Interface

The program will feature world-renowned experts presenting the latest research on immune checkpoint inhibitors, tumor microenvironment modulation, microbiota-driven resistance, and next-generation immunotherapies. From keynote lectures to selected abstracts and sponsor sessions, the conference is designed to foster collaboration and inspire breakthrough ideas.

As a committed partner, Quimigen will be present throughout the event to support and engage with the scientific community. We invite all attendees to visit our booth and discover how our innovative solutions are empowering immuno-oncology research across Europe and beyond.